Introduction
Rel/NF-kB transcription factors are induced in response to many signals that lead to cell growth, dierentiation, in¯ammatory responses, the regulation of apoptosis, and neoplastic transformation (Pahl, 1999) . The pivotal role played by these transcription factors is illustrated not only by the great diversity of genes that they regulate, but also by the large variety of stimuli that lead to their activation.
As described extensively in this issue, the Rel/NF-kB transcription factor family is comprised of several structurally-related proteins that exist in organisms from insects to humans. The vertebrate family includes ®ve cellular proteins: c-Rel, RelA, RelB, p50/p105, and p52/p100.
As homodimers or heterodimers, vertebrate Rel/NFkB proteins bind to a set of related DNA target sites, collectively called kB sites, and directly regulate gene expression. Thus, even a single cell can have a combinatorially diverse array of dimeric complexes, the most common of which is called NF-kB and consists of a p50/RelA heterodimer. The dierent Rel/ NF-kB proteins show distinct abilities to form dimers, distinct preferences for dierent kB sites, and distinct abilities to bind to IkB inhibitor proteins (Chen and Ghosh, 1999) . Thus, dierent Rel/NF-kB complexes can be induced in dierent cell types and by distinct signals, can interact in distinct ways with other transcription factors and regulatory proteins, and can regulate the expression of distinct gene sets. These types of considerations are likely to be responsible for the sometimes opposite eects of Rel/NF-kB complexes in dierent cell types.
The regulation of Rel/NF-kB transcription complexes is now known in some detail (Karin, 1999) . In most cell types, these complexes exist in a latent, inactive form in the cytoplasm where they are bound to any of several related IkB inhibitor proteins. The vertebrate IkB proteins include IkBa, IkBb, IkBe, IkBg, p105, p100, and Bcl-3, among others. Although activation of Rel/NF-kB proteins can follow a variety of pathways, the most common proximal step appears to occur via induced phosphorylation of IkB at two Nterminal Ser residues by a large IkB kinase complex (IKK), and phosphorylation of IkB leads to its degradation by the proteasome. The freed Rel/NF-kB complex can then enter the nucleus and bind to DNA. However, in certain cell types, such as B cells, some neurons (Kaltschmidt et al., 1994) , human thymocytes (Korner et al., 1991) , Sertoli cells (Del®no and Walker, 1998) , and photoreceptor cells (Krishnamoorthy et al., 1999) , there is a considerable amount of constitutively active, nuclear kB site-binding activity. In addition, there is accumulating evidence that many tumor cells have constitutive nuclear kB site-binding and transactivation activity (Rayet and GeÂ linas, 1999) .
Structurally, Rel/NF-kB proteins are related through an approximately 300 amino acid (aa) domain, called the Rel homology (RH) domain, which contains sequences essential for dimerization, DNA binding, and nuclear transport (Chen and Ghosh, 1999) . Cterminal to the RH domain, one class of Rel proteins (c-Rel, RelA and RelB) has transactivation domains. The second class of Rel proteins can exist either as short, active DNA-binding proteins (p50 and p52) or inactive proteins (p105 and p100), which contain additional C-terminal inhibitory domains related to the IkB proteins. All IkB proteins have a core domain, which consists of multiple, ankryin repeats necessary for protein ± protein interactions with Rel proteins. The best-studied IkB protein, IkBa, has an N-terminal regulatory domain containing the two Serine residues that are phosphorylated by IKK and lysine residues to which ubiquitin is conjugated.
The ®rst evidence indicating that Rel/NF-kB transcription factors might be involved in blocking apoptosis came from the study of the retroviral oncoprotein v-Rel (Gilmore, 1999) . v-Rel is encoded by the avian Rev-T retrovirus that causes rapidly fatal lymphoid tumors in young birds, and transforms and eciently immortalizes chicken lymphoid cells in tissue culture. In 1991, Neiman et al. showed that v-Rel-transformed chicken tumor cells were resistant to apoptosis-inducing stimuli, such as radiation and dexamethasone, when grown in cell culture (Neiman et al., 1991) . That this block to apoptosis was due to a direct eect of v-Rel was shown by White et al. (1995) , who demonstrated that chicken lymphoid cells transformed in vitro by a temperature-sensitive v-Rel mutant underwent apoptosis when shifted to the nonpermissive temperature.
Within the last 4 years, abundant evidence has implicated cellular Rel/NF-kB transcription factors in the control of apoptosis in many systems. In this review, both the inhibitory and the promoting roles of Rel/NF-kB transcription factors in apoptosis are discussed. Examples of the protective and apoptosispromoting roles for Rel/NF-kB are summarized in Tables 1 and 2. NF-kB and the immune system NF-kB as a survival factor NF-kB was originally identi®ed as a B-cell nuclear factor (Sen and Baltimore, 1986) . Therefore, it is perhaps not surprising that the ®rst evidence for a role of cellular Rel/NF-kB transcription factors in the regulation of apoptosis also came from the study of B lymphocytes (reviewed in . Rel/ NF-kB activity was shown to inhibit apoptosis in WEHI 231 immature B-lymphoma cells, which, like many B cells, have constitutive nuclear Rel/NF-kB activity composed primarily of p50/c-Rel and lesser amounts of p50/RelA. In these cells, engagement of surface IgM by anti-IgM antibodies causes a transient increase in DNA-binding activity by Rel/NF-kB family transcription factors, which is followed by a decrease in Rel/NF-kB DNA-binding activity and apoptosis. Treatment of WEHI 231 cells with inhibitors of NFkB induction, including the proteasome inhibitor Ntosyl-L-phenylalanine chloromethyl ketone (TPCK) and microinjection of GST-IkBa or an antibody to cRel, sensitizes these cells to anti-IgM-induced apoptosis (Wu et al., 1996a) . In contrast, overexpression of c-Rel protects these cells from apoptosis (Wu et al., 1996b) . c-myc is thought to be an essential target gene for the Rel/NF-kB-mediated block to apoptosis in WEHI 231 cells Wu et al., 1996b) .
As with anti-IgM antibodies, treatment of WEHI 231 cells with TGFb-1 also induces apoptosis and causes a decrease in c-myc expression (Arsura et al., 1996) . In this case, the reduction in c-myc expression results from a TGFb-1-mediated increase in IkBa expression, which decreases Rel/NF-kB DNA-binding activity. Engagement of the CD40 receptor can protect these cells from TGFb-1-induced apoptosis by maintaining high levels of NF-kB activity and c-myc expression.
However, there may be dierences between WEHI 231 cells and primary B cells in the NF-kB-mediated block to apoptosis. That is, the expression of c-myc is normal in resting and IgM-stimulated primary B cells from c-rel knockout mice, indicating that the target gene(s) regulated by c-Rel that are important for preventing apoptosis may dier between normal B cells and the immortalized WEHI 231 B cells (Grumont et al., 1998) . Moreover, the analysis of c-rel and p50 single knockout mice indicates that p50, but not c-Rel, is required for the survival of quiescent B cells, whereas c-Rel and p50 are each required for the survival of mitogen-activated B cells (Grumont et al., 1998) . Furthermore, B cells from rela/c-rel double knockout mice have a greatly reduced lifespan Grossmann et al., 1999) .
NF-kB as an inducer of cell death
Activation-induced cell death (AICD), a form of apoptosis, is the major mechanism by which immune cell homeostasis is maintained. In mature T cells, AICD occurs via a signal transduction pathway that is initiated by engagement of Fas by its ligand. Fas belongs to the tumor necrosis factor (TNF) death receptor family. Recently, it has been shown that NFkB activates expression of Fas-ligand (FasL) following T-cell receptor engagement (Kasibhatla et al., 1999; Matsui et al., 1998) , hence giving NF-kB a proapoptotic role in AICD. Furthermore, DNA-damaging agents also induce expression of Fas ligand via activation of NF-kB in T lymphocytes (Kasibhatla et al., 1998) . Interestingly, some apoptosis-resistant T cells have a de®ciency in NF-kB-mediated induction of FasL transcription (Teixeiro et al., 1999) .
Context-dependent regulation of apoptosis
The dual role for NF-kB in controlling immune cell apoptosis has also been shown by recent in vivo studies that highlight the importance of contextdependent regulation of apoptosis. Using transgenic mice expressing speci®cally in T cells a`superrepressor' form of IkBa, which lacks sequences required for signal-induced degradation, it was shown that NF-kB has a promoting role in a-CD3-mediated apoptosis of double-positive CD4 + CD8 + thymocytes. This was shown to be linked to downregulation of the anti-apoptotic Bcl-X L protein (Hettman et al., 1999) . Interestingly, double-positive T cells expressing the IkBa super-repressor were protected from a-CD3-mediated-apoptosis, but were still sensitive to g irradiation-induced cell death. On the other hand, Wang et al. (1999d) showed that an NF-kB/c-myc pathway is required for survival of immature thymocytes. That is, CD4 + CD8
+ thymocytes from mice induced to undergo apoptosis by treatment with the glucocorticoid dexamethasone had increased expression of IkBa and IkBb, and a consequent decrease in DNA binding by NF-kB. Moreover, cmyc expression was down-regulated in the dexamethasone-treated animals and ectopic expression of c-myc was protective (Wang et al., 1999d) . Thus, depending on the inducing signal, on the one hand glucocorticoids and on the other T-cell receptor-mediated activation, NF-kB can have opposite eects on apoptosis in a single cell type. Similarly, in a T-cell hybridoma cell line, NF-kB has been reported to have pro-and anti-apoptotic eects depending on the stimulus. In these cells, the induction of apoptosis by glucocorticoids could be facilitated by inhibition of NF-kB, whereas apoptosis induced by treatment with phorbol ester and ionomycin, which mimics T-cell receptor activation, required activation of NF-kB and Continued the consequent up-regulation of FasL transcription . NF-kB can also in¯uence the apoptotic response dierently depending on the developmental stage of immune cells. For example, overexpression of RelA causes cell-cycle arrest that is followed by apoptosis in the pro-B cell line 220 ± 8, whereas overexpression of RelA in the WEHI 231 immature B-cell line or in the mature B-cell line M12 does not induce apoptosis (Sheehy and Schlissel, 1999) . In addition, the triggering of apoptosis in the 220 ± 8 cell line is speci®c to RelA: c-Rel does not induce cell-cycle arrest and apoptosis in these cells (Sheehy and Schlissel, 1999) .
A protective role for NF-kB in TNFa-induced cell death Tumor necrosis factor a (TNFa) was ®rst identi®ed as a serum factor from lipopolysaccharide (LPS)-treated mice that could induce hemorragic necrosis in tumors. It is now known that TNFa is a pro-in¯ammatory cytokine that is produced mainly, but not exclusively, by activated macrophages. TNFa production is induced by cytokines and other activators, such as LPS and viruses. TNFa has several functions, including roles in in¯ammation, immunoregulation, proliferation, and anti-viral response (reviewed in JaÈ aÈ ttelaÈ , 1991).
The diverse actions of TNFa are mediated by two receptors, TNF-R1 (p60) and TNF-R2 (p80), both of which belong to a large receptor family. Most cell types and tissues express both TNF receptor types (Tartaglia and Goeddel, 1992) . TNFa binding to TNF-R1 leads to activation of NF-kB and AP-1, which culminates in a proin¯ammatory and immunomodulatory response (Ashkenazi and Dixit, 1998) . However, in certain cell types and under certain conditions, TNFa can induce apoptosis (reviewed in Van Antwerp et al., 1998) . The duality of the TNF-R1 signaling became clear through the identi®cation of two distinct TNF-R1 intracellular pathways: a pro-apoptotic pathway that is mediated by FADD and an anti-apoptotic pathway, which is mediated by TRAF2 (Hsu et al., 1996a) and, in some cell types, by the Akt kinase (Ozes et al., 1999; Romashkova and Makarov, 1999) , that leads to activation of NF-kB (Hsu et al., 1996a) (Figure 1) .
Members of the TNF receptor superfamily share a cytoplasmic domain, termed the death domain, which is a protein ± protein interaction motif critical for the engagement of downstream signaling components. Binding of TNFa to TNF-R1 leads to trimerization of the receptor, followed by recruitment of several proteins to the cytoplasmic domain of the receptor. For the pro-apoptotic pathway, the engaged TNF-R1 binds to the adaptor molecule FADD through its death domain and this complex recruits pro-caspase-8 through both of their death eector domains (DED). A second pro-apoptotic response through TNF-R1 occurs by recruitment of RAIDD/CRADD, which further recruits pro-caspase-2 to the receptor signaling The examples in the list above are ones that have shown a direct functional involvement of NF-kB in the apoptotic response either by manipulating it pharmacologically or genetically. Abbreviations: Cells: A549 cell line=nonsmall cell lung cancer; BJAB=Burkitt lymphoma; CEM=acute T cell leukemia; CHO=chinese hamster ovary cells; MCF7=breast cancer cell line; PBL=peripheral blood leukocytes; PC12=rat pheochromocytoma cell line; T24=TNFa resistant cell line human bladder cancer. CHX=cycloheximide; CPT11=an analog of campthecin, a topoisomerase I inhibitor; GSNO=S-nitrosoglutathione (nitric oxide donor); mutant IkBa, a nonphosphorylatable and nondegradable IkBa; LPS=lipopolysaccharide; PDTC=pyrrolidine dithiocarbamate; PPAR=Peroxisome proliferator-activated receptor; p50 NLS peptide=cell permeable peptide inhibitor of nuclear translocation of NF-kB; TCR=T cell receptor; TGF-b1=transforming growth factor-b1; TNF=tumor necrosis factor; TPCK=N-a-tosyl-L-lysine chloromethyl ketone, a protease inhibitor Figure 1 Engagement of the tumor necrosis factor (TNF) receptor (TNF-R1) activates competing pathways: a proapoptotic pathway and an anti-apoptotic pathway. Binding of TNF to TNF-R1 induces trimerization of the receptor, and this clustering leads to the recruitment of adaptor and eector molecules. On the one hand, recruitment of FADD and caspase-8 to the clustered receptor complex leads to apoptosis. On the other, recruitment of TRADD, RIP and TRAF proteins leads to activation of NF-kB, which initiates an anti-apoptotic pathway. Activation of NF-kB proceeds through a pathway that culminates in activation of the IkB kinase (IKK) complex. In some cells (dashed arrows), TNF cooperatively activates NF-kB through a PI-3 kinase?Akt pathway, which also leads to activation of IKK. See text for more details on these pathways complex (Duan and Dixit, 1997) . On the anti-apoptotic branch of TNF-R1 signaling is ®rst the recruitment of the adaptor molecule TRADD to the cytoplasmic domain. TRADD can then recruit TRAF2 that recruits RIP1 (receptor interacting protein), and this leads to activation of NF-kB. However, this signaling pathway has primarily been determined through protein overexpression studies in tissue culture, and it is important to note that TRAF2-de®cient cells have no defect in NF-kB activation in response to TNFa, suggesting that there are TRAF2-independent pathways or that other molecules can substitute for TRAF2 (Yeh et al., 1997) . In contrast, the importance for RIP1 in mediating the signal from the receptor to NF-kB activation was shown by the ®nding that RIP1-de®cient cells are impaired for activation of NF-kB (Kelliher et al., 1998) . RIP1 is a death domain-containing protein, which has a Ser/Thr kinase activity; however, the kinase activity of RIP1is not required for activation of NF-kB (Stanger et al., 1995) . Two other RIP-related proteins, RIP2 and RIP3, have recently been identi®ed McCarthy et al., 1998; Sun et al., 1999; Thome et al., 1998; Yu et al., 1999) . All RIP family members share a common N-terminal kinase domain, yet they have distinct C termini. For example, RIP2 has a CARD domain (caspase-recruitment domain) at its C terminus instead of the death domain found in RIP1. RIP2 is recruited to TNF-R1 and CD40, and it has also been shown to interact with H-IAP2, CARD4, TRAF1, 5, 6, but not with TRAF2, 3 or 4 (Bertin et al., 1999; McCarthy et al., 1998) . Expression of these RIP2-interacting proteins is sucient to activate NF-kB in many cell types. The unique C-terminal domain of RIP3 binds RIP1 and this binding can attenuate both RIP1 and TNF-R1-induced activation of NF-kB (Sun et al., 1999; Yu et al., 1999) . In addition, overexpression of RIP3 is a potent inducer of apoptosis by selectively binding large prodomain initiator caspases (Sun et al., 1999) .
It is not known precisely what joins the TNF signaling pathway to the NF-kB pathway. That is, how does the TNFR1-TRADD-RIP1 complex stimulate the IKK complex? A recently identi®ed protein, CLAP (CARD-like apoptotic protein) (Srinivasula et al., 1999) (also called BCL-10/CIPER/c-E10/ CARMEN) (Costanzo et al., 1999; Koseki et al., 1999; Thome et al., 1999; Willis et al., 1999; Zhang et al., 1999) , could ful®ll this role. The CLAP protein has two domains: a The examples in the list above are ones that have shown a direct functional involvement of NF-kB in the apoptotic response either by manipulating it pharmacologically or genetically. Abbreviations: SN-50=Recombinant peptide that contains the p50 NLS (aa360-369) and selectively blocks nuclear translocation of NF-kB; PDTC=Pyrrolidine dithiocarbamate ± an anti-oxidant; AT=Ataxia telangiectasia; Forskolin=an activator of cAMP signaling and T-cell activation; a-CD3 a physiological stimulus involved in thymocyte selection CARD domain for oligomerization and a C-terminal domain. Overexpression of the CARD domain of human CLAP can abrogate TNFa-induced activation of NF-kB (Srinivasula et al., 1999) . In addition, CLAP-induced activation of Rel/NF-kB can be inhibited by dominant-negative NIK and IKK proteins and by a super-repressor form of IkBa, but not by a dominant-negative RIP1 (Koseki et al., 1999; Srinivasula et al., 1999) . These ®ndings position CLAP upstream of NIK/IKK and downstream of RIP1. Interestingly, overexpression of mutant CLAP proteins that cannot induce apoptosis or NF-kB has been seen in several human lymphomas (Zhang et al., 1999) . TNF-R1-mediated activation of NF-kB is also under negative regulation. For example, a ubiquitin-homology protein, DAP-1, has recently been shown to bind the death domain of TNF-R1 and suppress NF-kB activation (Liou and Liou, 1999) . Moreover, overexpression of DAP-1 alone can induce apoptosis and DAP-1-induced apoptosis can be blocked by a dominant-negative form of FADD (Liou and Liou, 1999) . One proposal is that DAP-1 serves as a docking site for assembly of intracellular death domaincontaining proteins. Alternatively, DAP-1, as a ubiquitin homology protein, may compete with ubiquitin for conjugation to IkB, without promoting degradation of IkB. Another negative regulator of TNF-R1, silencer of death domain (SODD) protein, has recently been shown to bind to the death domain of TNF-R1, and overexpression of SODD blocks the ability of TNF to activate NF-kB and to cause cell death (Jiang et al, 1999) .
As mentioned above, the phosphatidylinositoal-3-OH kinase (PI-3K) to Akt kinase pathway has also recently been implicated in activation of NF-kB in response to TNFa. Speci®cally, in 293 cells, HeLa cells, and ME-180 cervical carcinoma cells, TNFa-induced activation of NF-kB can be blocked by a dominantnegative Akt kinase, and Akt can associate with, phosphorylate, and activate IKKa after treatment with TNFa (Ozes et al., 1999) . In these cells, the TRAF?NIK and PI-3K?Akt pathways appear to cooperate for activation of NF-kB by phosphorylating dierent activating residues on IKKa. However, in other cells, such as human skin ®broblasts and rat synoviocytes, the PI-3K?Akt pathway does not appear to be involved in TNFa-mediated activation of NF-kB (Romashkova and Makarov, 1999).
NF-kB and liver apoptosis
In the liver, NF-kB prevents apoptosis and has a positive role in regeneration (Taub, 1998) . One of the ®rst observations that implicated NF-kB in the regulation of liver apoptosis was the embryonic death of rela knockout mice due to hepatocyte apoptosis (Beg et al., 1995) . Moreover, mouse embryonic ®broblasts and macrophages from rela knockout mice are more susceptible to TNFa-induced apoptosis, and this sensitivity can be reversed by introduction of the wild-type rela gene (Beg and Baltimore, 1996) . c-Rel may partially compensate for RelA in blocking liver apoptosis in that c-rel/rela double knockout mice show liver degeneration approximately 1.5 days earlier than rela single knockout mice (Grossmann et al., 1999).
Consistent with a role for Rel/NF-kB complexes in embryonic liver survival, IKKb-de®cient mice also die at about embryonic day 13/14.5, due to liver degeneration and hepatocyte apoptosis (Li et al., 1999a,b; Tanaka et al., 1999) . The embryonic liver apoptosis in RelA-de®cient and in IKKb-de®cient mice appears to be due to increased sensitivity of these hepatocytes to circulating TNFa in that mice that are doubly-de®cient for either RelA and TNFa or IKKb and TNF-R1 do not show embryonic liver apoptosis (Doi et al., 1999; Li et al., 1999a) . Moreover, a role for NF-kB in preventing apoptosis during liver regeneration was illustrated by the use of adenoviral vectors expressing a super repressor form of IkBa, whereby inhibition of NF-kB led to an increase in apoptosis and liver dysfunction (Iimuro et al., 1998) .
Transforming growth factor-b1, well known for its role as an immunosuppressant, can inhibit B-cell growth by inducing apoptosis. Interestingly, certain chemical promoters of liver tumors, such as phenobarbital and clo®brate, enhance NF-kB activation and inhibit TGF-b-induced apoptosis in a hepatoma cell line (Buchmann et al., 1999) . TGF-b induced apoptosis of hepatocytes may be due to stabilization of IkBa and inactivation of NF-kB (Arsura et al., 1997) . A normal hepatocyte cell line that expresses constitutive NF-kB can be induced to undergo apoptosis if microinjected with IkB proteins or treated with TGF-b1 . Furthermore, c-myc cooperates with NF-kB in promoting murine hepatocyte survival (Bellas and Sonenshein, 1999) . Thus, the accumulating data suggest a role for NF-kB in the prevention of apoptosis in adult and fetal hepatocytes.
However, NF-kB has also been shown to have a pro-apoptotic role in hepatocytes. For example, Dengue-virus-infected HepG2 hepatocytes undergo apoptosis in vitro, and treatment of these cells with NF-kB decoys (double-stranded NF-kB binding sites) inhibits the virally-induced cell death, implicating NFkB in the promotion of apoptosis (Marianneau et al., 1997) . On the other hand, Hepatitis C virus (HCV) core protein inhibits TNFa-mediated apoptosis by activating NF-kB in the same HepG2 hepatocytic cell line (Marusawa et al., 1999) .
NF-kB and the nervous system
A pro-apoptotic role for NF-kB in neurons Several studies have shown that NF-kB promotes apoptosis in a variety of in vitro neuronal cell injury models (Clemens et al., 1997 (Clemens et al., , 1998 Grilli et al., 1996; Grimm et al., 1996; Lin et al., 1995a; Marinovich et al., 1996) . For example, treatment of rat primary neuronal cultures and hippocampal slices with the neurotoxin glutamate induces NF-kB activity and apoptosis, and activation of NF-kB in these cells can be inhibited by aspirin and salicylates, which also provides protection to these cells from glutamate-induced apoptosis (Grilli et al., 1996) .
Recently, two reports using animal models have demonstrated that NF-kB also has a pro-apoptotic eect in neuronal cells in vivo. In one study, investigated the role of NF-kB in apoptosis as induced by the NMDA receptor in rat striatal medium spiny neurons, which is an excitotoxic Huntington's disease model. Administration of the excitotoxin quinolic acid, which activates the NMDA receptor and induces apoptosis in the rat striatum, caused increased nuclear translocation of an NF-kB complex that contained the RelA and c-Rel subunits. NMDA receptor activation by quinolic acid resulted in NF-kBdependent upregulation of two death-promoting genes, c-myc and p53. Moreover, inhibition of NF-kB induction by treatment with the SN50 peptide, a peptide containing the p50 nuclear localization sequence (Lin et al., 1995b) , also blocked induction of p53 and c-myc and reduced apoptosis. In the second study, Schneider et al. (1999) used a transgenic mouse containing a chimeric b-globin gene under transcriptional control of NF-kB consensus binding sites in a model for strokes. Upon induction of focal cerebral ischemia in these mice, NF-kB translocated to the nucleus of neuronal cells, which showed increased DNA binding by p50/RelA and p50/p50 complexes and increased reporter gene transcription. Moreover, p50 knockout mice had signi®cantly reduced ischemic damage as compared to wild-type mice, suggesting that the absence of NF-kB provides protection from neuronal cell death. However, con¯icting results have been obtained using this model, in that Botchkina et al. (1999) observed decreased RelA protein levels and DNA binding in the ischemic area that is undergoing apoptosis.
NF-kB as a blocker of apoptosis in the nervous system
Several lines of evidence suggest that Rel/NF-kB transcription factors can also have a survival role in neurons. For example, the b-amyloid peptide associated with Alzheimer's disease may cause its neurodegenerative eects by downregulating NF-kB activity. Cortical neurons exposed to b-amyloid peptide show increased levels of IkBa protein and mRNA and a consequent decrease in NF-kB activity (Bales et al., 1998) . Moreover, pretreatment of these cortical neurons with an antisense oligonucleotide to IkBa mRNA protects them from b-amyloid peptide-induced death. A protective role for NF-kB in Alzheimer's disease was also reported by Guo et al. (1998) , who demonstrated that the neuroprotective form of soluble b-amyloid peptide precursor protein can activate NFkB and prevent apoptosis induced by the b-amyloid peptide.
Unlike other systems where TNFa induces cell death, TNFa may sometimes have a neuroprotective role in response to brain injury. In primary hippocampal neurons, treatment with TNFa protected the cells from hypoxia-induced apoptosis by inducing Bcl-2 and Bcl-X L expression via activation of NF-kB (Tamatani et al., 1999) . Suppression of TNFainduced activation of NF-kB by expression of an IkBa super-repressor abolished the up-regulation of Bcl-2 and Bcl-X L and thus, the neuroprotective eect of TNFa. However, it is not known whether the upregulation of Bcl-2 and Bcl-X L in this study is directly due to NF-kB. Interestingly, bcl-x L -de®cient mice die during embryogenesis with severe apoptosis of hematopoetic cells and neurons (Motoyama et al., 1995) , and thus NF-kB may have a role in brain development.
The dual role of NF-kB in regulating apoptosis in the nervous system is likely attributable to several considerations: the cell type; the Rel/NF-kB family members found in the active complex; the type of stimulus; and the cellular context. Nevertheless, it is also of particular interest that a neuron-speci®c kB sitebinding factor (NkBF) has been identi®ed that does not appear to include any Rel/NF-kB family members (Moerman et al., 1999) . Thus, it will be important to determine whether it is NF-kB, NkBF or both that are responsible for the kB site-mediated eects on apoptosis that occur in neurons.
NF-kB and viruses: a role for apoptosis in replication and pathogenesis
The response of many cells to viral infection is the induction of apoptosis. Therefore, many viruses have developed strategies to block apoptosis, and thus enhance their replicative eectiveness or pathogenesis. Many viruses have also been shown to activate NF-kB, either to increase their replication because they have NF-kB binding sites in their promoters, to enhance their pathogenicity, or to block or promote apoptosis. For example, HIV-1 has two kB sites in its promoter that are essential for its ecient replication under certain conditions. In addition, NF-kB can protect HIV-1-infected myeloid cells from apoptosis, as inhibition of the constitutive NF-kB activity in these cells induces apoptosis (DeLuca et al., 1998). However, HIV-1 may also induce apoptosis through NF-kB in some situations; for example, the HIV-1-encoded transcriptional transactivator TAT has been shown to render cells sensitive to apoptosis by inducing NF-kB (Westendorp et al., 1995) .
Several other viruses also appear to induce NF-kB in order to block apoptosis. For example, NF-kB has also been shown to block apoptosis induced by the Hepatitis C virus core protein (Marusawa et al., 1999) or by encephalomyocarditis virus (EMCV). In the case of EMCV, its ability to suppress apoptosis through NF-kB has been clearly tied to its pathogenicity in that EMCV-infected p50 knockout mice have increased apoptosis but survive EMCV infection, whereas normal mice die (Schwartz et al., 1998) . Epstein-Barr virus (EBV) can eciently immortalize human B cells in large part due to the activity of the virally-encoded LMP-1 protein, which promotes the constitutive activation of NF-kB (Cahir McFarland et al., 1999) . EBV-induced B-cell immortalization and resistance to apoptosis induced by low serum correlates with the expression of Bcl-2 and A20, a gene that can be regulated by NF-kB (Spender et al., 1999) . In contrast to those viruses, Dengue virus and Sindbis virus-induced activation of NF-kB is associated with the promotion of virallyinduced apoptosis (Lin et al., 1995a; Marianneau et al., 1997) .
Unlike those viral products that induce NF-kB activity, the E1A protein of adenovirus sensitizes cells to g-irradiation and TNFa by inhibiting NF-kB (Shao et al., 1997 (Shao et al., , 1999 . E1A inhibits NF-kB by blocking IKK activity, and this eect requires the p300 and Rb binding domains of E1A (Shao et al., 1999) .
How do Rel/NF-kB transcription factors regulate apoptosis?
There are three general models by which Rel/NF-kB transcription factors may regulate apoptosis: (1) by the direct regulation of genes that inhibit or promote apoptosis; (2) by the regulation of the cell cycle, which then desensitizes or sensitizes a cell to apoptotic signals; and (3) by interaction with cellular proteins whose levels aect the life balance of the cell.
Target genes involved in the protective eect of NF-kB
The mechanism by which NF-kB promotes cell survival is almost certainly due, in part, to the upregulation of anti-apoptotic genes, a number of which have recently been identi®ed ( Table 3 ). The general strategy for claiming that an NF-kB target gene is involved in cell survival is to show that the gene is directly activated by NF-kB under apoptosisinducing conditions, that inhibition of the gene (e.g., by antisense treatment) abrogates its protective eect, and that ectopic expression of the gene can protect the cell from the apoptotic signal.
The Bcl-2 family of proteins includes some of the most important cellular regulators of apoptosis (Reed, 1998) . Although bcl-2 itself does not appear to be a target gene for Rel/NF-kB, several groups have recently identi®ed anti-apoptotic members of the bcl-2 family as gene targets for Rel/NF-kB transcription factors. These include the genes encoding Bcl-2-like proteins A1/B¯1, Bcl-X L and Nr13, all of which contain functional upstream kB sites. Recently, three groups identi®ed A1/B¯1 as an NF-kB-dependent transcriptional target Wang et al., 1999b; Zong et al., 1999) . The promoter of A1 contains a single kB site that is activatable by NF-kB. In addition, overexpression of A1 was found to protect HeLa cells from TNFa-induced apoptosis and B cells from antigen receptor ligation-induced apoptosis. Furthermore, the high-level expression of A1 in immune tissues correlates with the protective role of NF-kB in the immune system ). A1 appears to suppress apoptosis, at least as induced by etoposide, by inhibiting cytochrome c release and inhibiting caspase-3 activation (Wang et al., 1999b) . However, as over-expression of A1 is only partially protective in these systems, other genes regulated by Rel/NF-kB are also likely to participate in the antiapoptotic program. In support of this proposal, two groups have recently shown that the bcl-X L gene also has NF-kB binding sites in its promoter and can be induced by cell survival signals such as CD40 Lee et al., 1999a) . Furthermore, Bcl-X L is down-regulated in thymocytes undergoing apoptosis after treatment with anti-CD3 (Hettmann et al., 1999) . Finally, the anti-apoptotic bcl-2 family member Nr13 has been shown to be up-regulated by v-Rel and to have a protective role in the chicken bursa of Fabricius, an organ responsible for avian B-cell development (Lee et al., 1999c) . However, in situations where Rel/NF-kB has been shown to protect from apoptosis, it probably does not always depend on the upregulation of the bcl-2 protective family members; for example, altered expression of Bcl-X L is not seen in dexamethasone-treated immature thymocytes, even though NF-kB can protect these cells from dexamethasone-induced apoptosis (Wang et al., 1999d) . Wang et al. (1998) identi®ed four genes ± TNFreceptor associated factors (TRAF1, TRAF2), and cellular inhibitors of apoptosis proteins (H-IAP1, H-IAP2) ± that are induced in HT1080 ®brosarcoma cells following treatment with TNFa. Protection from TNFa-mediated cell death in RelA-de®cient embryonic ®broblasts required the simultaneous expression of all four genes, whereas overexpression of H-IAP1 and H-IAP2 was sucient to block etoposide-mediated apoptosis. These four gene products could be involved in the resistance of cells to TNFa-mediated apoptosis by blocking the activation of caspase-8, a cell-death protease involved in the apoptotic process. It is not clear whether H-IAP2 is a direct target gene for NFkB, however, there is good evidence that the H-IAP1 gene is a direct target. First, TNFa induces H-IAP1, but not H-IAP2, in an NF-kB-dependent manner in Jurkat cells (Chu et al., 1997) , and H-IAP1 is induced in an NF-kB-dependent manner in cells overexpressing protein kinase Cm (Johannes et al., 1998) . Second, the chicken homolog of H-IAP1, ch-IAP1, is upregulated by both v-Rel and a C terminally-truncated form of cRel (You et al., 1997) . Third, Erl et al. (1999) have shown that the H-IAP-1 gene has a kB site in its promoter, and that smooth muscle cells at high density have high nuclear NF-kB activity, are resistant to apoptosis, and show increased expression of the H-IAP1 gene. In addition, X-IAP, another member of the inhibitors of apoptosis family, is an NF-kB-regulated gene that can protect cells from TNFa-mediated apoptosis (Stehlick et al., 1998b) . Several other protective gene targets for Rel/NF-kB have also been identi®ed (see Table 3 ). An immediateearly response gene, IEX-1L, was identi®ed as an NFkB target gene that plays a protective role following treatment of cells with TNFa or Fas (Wu et al., 1998) ; however, the relevance of IEX-1L expression has recently been questioned (Schafer et al., 1999) . A20 is a zinc ®nger protein that can inhibit TNFa-mediated apoptosis. Even though the A20 gene contains a kB site in its promoter (Krikos et al., 1992) , A20 by itself cannot rescue RelA-de®cient cells from TNFa-induced cell death (Beg and Baltimore, 1996) .
Finally, the gene encoding the tumor suppressor p53 also has a kB site in its promoter, and expression of p53 can be induced through this site following treatment with TNFa (Wu and Lozano, 1994) . Based on the well-known role of p53 in protecting cells from DNA damaging agents by arresting cells at the G1/S phase of the cell cycle, p53 may also participate in some anti-apoptotic responses mediated by Rel/NF-kB proteins. Moreover, NF-kB and p53 are both induced by certain forms of cell stress, such as UV radiation, that lead to DNA damage.
Target genes involved in death signaling by Rel/NF-kB
Much less is known about target genes that might be involved in cells where Rel/NF-kB complexes induce apoptosis. However, there is accumulating evidence that induction of NF-kB activity can sensitize some cells to apoptosis-inducing agents that act through or cooperate with the Fas pathway due to the ability of NF-kB to activate the genes encoding Fas ligand or Fas (the receptor). For example, the promoters of the human and murine Fas ligand have kB sites and can be up-regulated by activation-induced cell death in T cells (Kasibhatla et al., 1999; Matsui et al., 1998) . In addition, Fas is up-regulated by NF-kB in Jurkat T cells induced to undergo apoptosis by treatment with phorbol ester and ionomycin .
It has not yet been shown that NF-kB can directly induce the expression of other pro-apoptotic genes, such as caspases or Bcl-2 pro-apoptotic family members. Nevertheless, the bcl-x gene can produce two gene products, Bcl-X L and Bcl-X S , by alternative splicing. Although Bcl-X L is protective, Bcl-X S is proapoptotic. Certainly, the identi®cation of bcl-x L as an NF-kB target gene (see above) indicates that NF-kB could have pro-apoptotic eects by inducing bcl-x expression under conditions where splicing to produce Bcl-X S is favored.
Regulation of the cell cycle by Rel/NF-kB
The link between the cell cycle and apoptosis provides a mechanism to balance between apoptosis and cell proliferation (reviewed in Evan and Littlewood, 1998; Kasten and Giordano, 1998) . Several observations have suggested coordination between the cell cycle and NF-kB activation. For example, two reports Hinz et al., 1999) have shown that NF-kB can activate the transcription of cyclin D1, a key positive regulator of the G1 to S phase progression. In both studies, inhibition of NF-kB by over-expression of an IkBa super-repressor led to delayed cell-cycle progression, and this eect could be rescued by ectopic expression of cyclin D1. However, in at least one study, Rel/NF-kB activity has also been associated with cell-cycle arrest. Namely, overexpression of chicken c-Rel in HeLa cells causes cell-cycle arrest, accompanied by a decrease in CDK2 kinase activity and increased levels of the tumor suppressor p53 and the CDK inhibitor p21 (Bash et al., 1997) .
In some cases, direct interactions between Rel/NFkB proteins and cell-cycle control proteins have been reported. For example, the INK4 CDK inhibitors, which cause cell-cycle arrest by inhibiting CDK4 and CDK6, can also bind to and inhibit NF-kB through their ankyrin repeats (Wol and Naumann, 1999) . Curiously, overexpression of the unrelated CDK inhibitor p27 increases transactivation by NF-kB (Wol and Naumann, 1999) . In addition, the cyclinE/ CDK2 complex, which is required for G1/S transition of the cell cycle, has been shown to interact with the C terminus of human c-Rel in G1/S-phase cells (Chen and Li, 1998) .
Interactions with proteins that aect the life balance of the cell
Although most studies have focused on the transcriptional regulatory activities of Rel/NF-kB transcription factors in the control of apoptosis, there is some evidence that these factors may aect the state of the cell through protein ± protein interactions. The best example may be the related transcriptional co-activator proteins CBP/p300. These co-activators interact with various proteins such as nuclear receptors, TFIIB, the cyclin E-CDK2 complex, c-Myb, p53, and RelA, and competition for binding to these co-activators by various transcription factors is thought to be important for the integration of several cell signaling pathways (Janknecht and Hunter, 1996) . Along these lines, the level of accessible p300 is less than that of RelA and can, therefore, limit RelA-mediated transactivation (Hottigen et al., 1998; Sheppard et al., 1998) . In a similar manner, the titration of p300 by activated RelA may aect other signaling pathways to in¯uence the state of the cell in a way that alters its susceptibility to apoptotic signals. For example, it has recently been shown that p53 and NF-kB can repress each other through interaction with the CBP/p300 pathway (Ravi et al., 1998b; Wadgaonkar et al., 1999; Webster and Perkins, 1999) . In addition, RelA can block apoptosis induced by a p53 binding protein, 53BP2 (Yang et al., 1999) .
In an example more directly related to the control of apoptosis, a B cell-speci®c TFIID subunit, TAFII105, has been shown to interact directly with the activation domain of RelA to mediate transcriptional activation. Blocking the normal function of TAFII105, either by expression of a dominant-negative mutant of TAFII105 or by reducing its endogenous expression levels with antisense RNA, sensitizes 293 cells to TNFa-induced apoptosis . Therefore, TAFII105 may function as a coactivator of NF-kB for the speci®c activation of antiapoptotic genes or, alternatively, in some other way the level of TAFII105 may control the susceptibility of cells to TNFa-induced apoptosis.
Turn about is fair play: eects of cell-death molecules on Rel/NF-kB
Caspases
In almost all cells, the apoptotic program is executed by a family of cysteine proteases called caspases, which cleave substrates C-terminal to Asp residues that fall within speci®c consensus sequences (reviewed in NunÄ ez et al., 1998). The substrates of caspases can be divided into two broad categories. One category of caspase substrates includes housekeeping or structural proteins, such as actin and nuclear lamins, whose cleavage leads to the disassembly of the cell. A second category contains regulators of apoptosis that are either activated or inactivated by caspase cleavage; for example, cleavage and inactivation of the antiapoptotic Bcl-2 protein promotes cell death in some cells.
As regulators of apoptosis, one might suspect that Rel/NF-kB transcription factors or proteins in the Rel/ NF-kB signaling pathway might be substrates for caspases. Recent evidence suggests that this is the case. Fas-induced apoptosis in Jurkat T cells leads to proteolytic cleavage of RelA and p50, which is dependent on caspase-3 activity (Ravi et al., 1998a) . We have also recently shown that chicken c-Rel has three caspase-3 cleavage sites (Barkett et al., 1999) and that it can be cleaved by caspase-3 in cells treated with TNFa and a proteosome inhibitor. In addition, other Rel/NF-kB family members can be cleaved by caspase-3 in vitro (Epinat and Gilmore, unpublished results). In each of these cases, one would hypothesize that inactivation of Rel/NF-kB by caspase-mediated cleavage would negate its anti-apoptotic eect and would push the cell towards apoptosis.
An alternative mechanism to inhibit NF-kB is to in¯uence the activity of IkB. In three settings, it appears that IkBa can be a direct substrate for a celldeath caspase. Work in our laboratory has shown that IkBa is a substrate for caspase-3 in v-Rel-transformed cells induced to undergo apoptosis (Barkett et al., 1997; White and Gilmore, 1996; White et al., 1995) . In these cells, cleavage of IkBa by caspase-3 occurs at an Asp residue that immediately precedes the sites of signalinduced phosphorylation. Similarly, an N-terminal cleavage of IkBa has also been seen in Ataxia Telengiectasia cells induced to undergo apoptosis by gamma irradiation (Jung et al., 1998) and in the 32D myeloid cell line treated with TNFa or deprived of IL-3 . In each of these settings, caspase-3 cleavage of IkBa would create a natural super-repressor form of IkBa, which may act to facilitate apoptosis by constitutively inhibiting NF-kB. That caspase-mediated cleavage of IkBa represents a pathway distinct from signal-induced proteasomemediated proteolysis of IkBa is further supported by the ®nding that phosphorylation of IkBa by IKK blocks its ability to be cleaved by caspase-3 in vitro (Barkett et al., 1997) .
IAPs
IAPs are inhibitors of apoptosis and act, directly or indirectly, as inhibitors of cell-death caspases (LaCasse et al., 1998) . One IAP family member, H-IAP1, is a target gene for NF-kB and also appears to regulate NF-kB activity. Speci®cally, Chu et al. (1997) have shown that overexpression of H-IAP1 activates NFkB-directed transcription by promoting IkBa degradation. Moreover, H-IAP1-mediated activation of NF-kB suppresses TNFa-induced apoptosis.
Bcl-2
The Bcl-2 family of mitochondrial proteins are key regulators of apoptosis, and Bcl-2 family members include anti-apoptotic (Bcl-2, Bcl-X L , Nr13, etc.) and pro-apoptotic (Bad, Bax, Bcl-X S ) proteins (reviewed in Reed, 1998). As mentioned above, several bcl-2 family member genes are upregulated by NF-kB, and the apoptotic eects of several stimuli, such as serum withdrawal, g-irradiation, and UV-radiation, that activate NF-kB are also inhibitable by overexpression of Bcl-2. However, in some cases, there may be a reciprocal eect of Bcl-2 on NF-kB. For example, Bcl-2 has been shown to have an inhibitory eect on NF-kB activity at several important regulatory steps: by stabilization of IkBa (Badrichani et al., 1999; deMoissac et al., 1998; Lin et al., 1995a) , by inhibiting transactivation of RelA (Grimm et al., 1996) , and by modulating nuclear levels of Rel family members (Ivanov et al., 1995) . The mechanisms by which Bcl-2 aects these regulatory steps are still unresolved, although hyperphosphorylation of IkBa has been shown to be involved in its stabilization by Bcl-2 (Badrichani et al., 1999) .
Cancer treatment: a role for NF-kB?
A role for NF-kB in cell proliferation and malignant transformation in vitro arises from several observations. First, stimulation of ®broblast proliferation by platelet-derived growth factor appears to require the delicate balancing of two pathways: one that leads to cell division, requires c-myc and is cytotoxic, and a second that blocks apoptosis and is mediated a Ras?PI-3K?Akt?IKK?NF-kB pathway (Romash-kova and Makarov, 1999) . Second, NF-kB activity is required for oncogenic transformation by Ras (Arsura et al., 1999; Mayo et al., 1997) , by Raf (Arsura et al., 1999) , and by Bcr-Abl (Reuther et al., 1998) . In the case of Ras transformation, NF-kB activity appears to be required to block apoptosis, such that the cell can withstand the oncogenic growth-promoting activity of Ras (Mayo et al., 1997) , and for focus formation (Arsura et al., 1999) . Thus, inhibiton of NF-kB by an IkBa super-repressor leads to the apoptotic death of Ras-transformed ®broblasts (Mayo et al., 1997) and reduced focus formation in Ras-transformed rat liver cells (Arsura et al., 1999) . Similarly, inhibition of NFkB with the IkBa super-repressor also blocks the tumorigenicity of Bcr-Abl-transformed cells in nude mice and the transformation of primary bone marrow cells by Bcr-Abl (Reuther et al., 1998) ; however, in this case, it is not clear if these eects are due to an antiapoptotic activity of NF-kB.
Several human cancer cells have constitutive nuclear NF-kB activity (Rayet and GeÂ linas, 1999) . These include tumor cell lines of lymphoid origin, such as T-cell lymphoma Hut 78 cells (Giri et al., 1998) , multiple myeloma (Feinman et al., 1999) and Hodgkin/ Reed Sternberg cells (Bargou et al., 1996 (Bargou et al., , 1997 Krappmann et al., 1999) . In addition, non-lymphoid cell lines exhibit enhanced NF-kB activity, including breast cancer cells (Nakshatri et al., 1997; Sovak et al., 1997) , ovarian cancer cells (Bours et al., 1994) , bladder cancer cells (Sumitomo et al., 1999) , melanomas (Shattuck-Brandt and Richmond, 1997), lung carcinoma (Batra et al., 1999; Mukhopadhyay et al., 1995) , thyroid carcinoma (Visconti et al., 1997) , pancreatic cancer cells (McDade et al., 1999; Wang et al., 1999c) , head and neck squamous cell carcinomas and ovarian carcinoma cell lines (Bours et al., 1994) .
Numerous tumor cells with elevated levels of NF-kB are resistant to apoptosis induced by chemotherapy, radiotherapy, and TNFa treatment (reviewed in Paillard, 1999) . Seminal work showing that inhibition of NF-kB nuclear translocation can sensitize cells to apoptosis-inducing stimuli known to activate NF-kB such as TNFa (Liu et al., 1996; Van Antwerp et al., 1996; Wang et al., 1996) , ionizing radiation, and the chemotherapeutic drug daunorubicin (Wang et al., 1996) provided in vitro evidence for the hypothesis that inhibition of NF-kB would be a likely approach to enhance anti-tumor therapy in tumors with constitutive NF-kB activity. Recently, Baldwin and co-workers showed that adenoviral delivery of a super-repressor form of IkBa sensitizes chemoresistant tumors to TNFa and to the chemotherapeutic drug CPT-11, leading to tumor regression (Wang et al., 1999a) . Similarly, Duey et al. (1999) have shown that the IkBa super-repressor can lead to the reduction of the growth of human head and neck squamous cell carcinomas in SCID mice.
In addition, several groups have shown that inhibition of NF-kB activation can increase the sensitivity of cancer cells to apoptosis-inducing stimuli in vitro. For example, Jeremias et al. (1998) showed that inhibition of NF-kB by the proteasome inhibitor ALLnL or the IkBa super-repressor caused an increased sensitivity to the induction of apoptosis by the TNF-related ligand TRAIL and by doxorubicin in otherwise resistant lymphoid cell lines and primary leukemic cells. Similar results have been obtained in lymphocytes, chronic lymphocytic leukemia (CLL)-derived lymphocytes, human cutaneous T-cell lymphoma Hut78 cells, and breast cancer cells (Giri et al., 1998; Masdehors et al., 1999; Sovak et al., 1997) .
Given the dual role of NF-kB in the control of apoptosis, one might not always expect that inhibiting the Rel/NF-kB activity would increase the sensitivity of tumor cells to apoptosis-inducing stimuli. Indeed, inhibition of NF-kB activity does not appear to aect the sensitivity of several tumor cell lines, including ones with no NF-kB activity (MCF7 breast cancer cells) or constitutive NF-kB activity (ovarian carcinoma cell line OVCAR-3), to a variety of chemotherapeutic agents (Bentires-Alj et al., 1999) . Furthermore, in at least one case, overexpression of the IkBa super-repressor has been shown to be oncogenic (van Hogerlinden et al., 1999) .
Summary
Among their many roles in cellular physiology, Rel/ NF-kB complexes control the susceptibility of cells to apoptosis-inducing agents. The eects of these transcription factors in regulating apoptosis have been particularly well-studied in immune cells, neurons, and the liver. An emerging picture is that, depending on a variety of circumstances, including the cell type and the inducing agent, Rel/NF-kB complexes can have pro-or anti-apoptotic eects. These eects are likely carried out by the activation of target genes that lead to dierent outcomes. However, under certain circumstances, it appears that proteins that directly control apoptosis ± such as caspases and Bcl-2 proteins ± can also have eects on the Rel/NF-kB signaling pathway. The control of apoptosis by Rel/NF-kB transcription factors has clear importance in normal processes, such as liver development and immune cell homeostasis. Moreover, the constitutive activity of Rel/NF-kB transcription factors in certain cancers appears to be important for their growth or resistance to induced apoptosis. Furthermore, these transcription factors may play a role in certain neurodegenerative diseases that are due to increased apoptosis. Therefore, agents that aect the ability of Rel/NF-kB transcription factors to control apoptosis are likely to have clinical relevance.
